What is the EVAX stock price prediction for next 2 weeks?

According to our price prediction algorithm,Evaxion Biotech A/S (EVAX) price will be around $4.71 in the next 2 weeks. This means it will decrease by -1.5041841004184162 from the last closing price. This prediction may vary from other time period filters for EVAX stock.

What can be the highest Possible price of EVAX stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, EVAX can achieve the highest price of $5.37 which is 12.43927067087498 higher than last closing price. This prediction may vary from other time period filters for EVAX stock.

What can be the lowest Possible price of EVAX stock in next 2 weeks?

As per the forecast and algorithmic analysis, EVAX stock price can be as low as $4.05 which is -15.255828399636027 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for EVAX stock.

Will EVAX stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that EVAX stock will lose-1.5041841004184162 in the next 2 weeks. This prediction may vary from other time period filters for EVAX stock.

What is EVAX stock last closing price?

Last closing price of EVAX stock was $4.77.

What is EVAX stock price prediction?

EVAX stock price prediction means predicting the future closing prices of EVAX stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of EVAX stock in a certain time period.

How we predict EVAX stock future prices?

If you are searching for EVAX stock forecast, analysis or price prediction, then you might be wondering what Evaxion Biotech A/S (EVAX) will do in the future. Our EVAX price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This EVAX price prediction will likely answer most of your questions.

How frequent we update EVAX stock predictions?

We are updating the forecasts for the EVAX stock on daily basis.

Is using ML forecasting for EVAX stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for EVAX stock same for all the time periods?

No, the prediction for EVAX stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Evaxion Biotech A/S Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$4.77-18.6%Since 2 Weeks

Predicted Price$4.71-1.5%For 2 Weeks

Upper Predicted Price$5.3712.44%For 2 Weeks

Lower Predicted Price$4.05-15.26%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of EVAX will decline by -1.50% over the next 2 Weeks and hit $4.71 by Tuesday, January 13, 2026. In that time frame, EVAX's share price is expected to range between $4.05 and $5.37.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jan 13, 2026	4.05	4.71	5.37
Jan 12, 2026	4.20	4.81	5.50
Jan 9, 2026	4.03	4.70	5.36
Jan 8, 2026	4.19	4.85	5.52
Jan 7, 2026	4.06	4.74	5.36
Jan 6, 2026	4.08	4.75	5.38
Jan 5, 2026	4.20	4.85	5.51
Jan 2, 2026	4.12	4.75	5.38
Jan 1, 2026	4.28	4.89	5.57
Dec 31, 2025	4.12	4.78	5.46

EVAX shares fell -0.21% in Wednesday, December 31, 2025's trading session, dropping from a previous close of $4.78 to move at $4.77. The stock demonstrated notable intraday movement (see EVAX's key stats for a full breakdown), fluctuating between $4.69 and $4.92, a +4.90% trading range. While recent weeks have seen some volatility, EVAX has managed to secure a -21.67% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 84.51K shares changing hands, 13.08K fewer than the previous session. This amounted to $403.12K in total market activity.

Will EVAX Continue Its Upward Trend?

According to analyst ratings and projections for EVAX, Evaxion Biotech A/S shares are anticipated to increase by +11.25%, potentially reaching $5.37 per share by January 13, 2026. Short-term technical indicators currently suggest a neutral sentiment for EVAX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the EVAX stock forecast, now is a good time to buy EVAX stock because its current trading price is +1.31% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on EVAX covering social and institutional perspectives.

EVAX Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into EVAX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 38.55% to 44.42%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 49.37%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.27%, maintains a neutral outlook for the long term. Insights into EVAX's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Evaxion Biotech A/S Monthly Forecast 2026

January 2026

According to our latest forecast models, Evaxion Biotech A/S (EVAX) is positioned to show a strong performance in January 2026. The price is predicted to move between $4.39 and $9.94, settling at an average of $7.41. This could translate to a +55.35% gain.

February 2026

Based on current market signals, Evaxion Biotech A/S is projected to trend february 2026. We forecast a trading range from $3.22 to $9.60, with a likely average price of $6.39. Investors could expect a potential return of +33.96%.

March 2026

Our predictive algorithms indicate Evaxion Biotech A/S stock may see a shift in March 2026. The expected range spans $2.01–$9.19, with an average target of $4.62. This represents a cautious outlook and a possible loss of -3.14%.

April 2026

Analyzing established trends, Evaxion Biotech A/S looks set to move in April 2026. Projections place the stock between $7.33 and $13.04, averaging around $10.55. This suggests a +121.17% gain from current levels.

May 2026

Market indicators suggest Evaxion Biotech A/S could experience notable changes during May 2026. Prices could fluctuate within $7.94 to $14.49, with a midpoint forecast of $11.44. The stock might deliver a +139.83% gain.

June 2026

Forecasting for June 2026, models estimate that Evaxion Biotech A/S may undergo key fluctuations. If trends hold, the stock might trade between $10.57 and $19.35, averaging $15.47. This signals a positive trajectory with potential returns around +224.32%.

July 2026

According to our latest forecast models, Evaxion Biotech A/S (EVAX) is positioned to show a strong performance in July 2026. The price is predicted to move between $8.57 and $19.44, settling at an average of $15.00. This could translate to a +214.47% gain.

August 2026

Based on current market signals, Evaxion Biotech A/S is projected to trend august 2026. We forecast a trading range from $8.09 to $19.98, with a likely average price of $15.13. Investors could expect a potential return of +217.19%.

September 2026

Our predictive algorithms indicate Evaxion Biotech A/S stock may see a shift in September 2026. The expected range spans $9.67–$22.17, with an average target of $20.48. This represents a positive outlook and a possible gain of +329.35%.

October 2026

Analyzing established trends, Evaxion Biotech A/S looks set to move in October 2026. Projections place the stock between $8.71 and $26.28, averaging around $21.61. This suggests a +353.04% gain from current levels.

November 2026

Market indicators suggest Evaxion Biotech A/S could experience notable changes during November 2026. Prices could fluctuate within $9.45 to $34.41, with a midpoint forecast of $30.93. The stock might deliver a +548.43% gain.

December 2026

Forecasting for December 2026, models estimate that Evaxion Biotech A/S may undergo key fluctuations. If trends hold, the stock might trade between $3.99 and $30.98, averaging $20.57. This signals a positive trajectory with potential returns around +331.24%.

EVAX's history of dividends and stock splits also plays a role in long-term investor confidence.